Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease.
作者： Nirmal Kaur , Thomas C. Mahl
DOI: 10.1023/B:DDAS.0000042246.58984.98
关键词: Pharmacotherapy 、 Immunology 、 Respiratory disease 、 Ulcerative colitis 、 Crohn's disease 、 Pneumocystis carinii 、 Infliximab 、 Inflammatory bowel disease 、 Medicine 、 Pneumonia
摘要:
springer.com
sci-hub.se 参考文章(19)
P. Gaustad, A. Warris, A. Bjorneklett, Invasive pulmonary aspergillosis associated with infliximab therapy. The New England Journal of Medicine. ,vol. 344, pp. 1099- 1100 ,(2001)
R L Deem, J Prehn, S R Targan, N M Carramanzana, D Shealy, C J Landers, S E Plevy, A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. Journal of Immunology. ,vol. 159, pp. 6276- 6282 ,(1997)
T. L. Tai, Pneumocystis carinii pneumonia following a second infusion of infliximab Rheumatology. ,vol. 41, pp. 951- 952 ,(2002) , 10.1093/RHEUMATOLOGY/41.8.951
Daniel Helbling, Thomas H Breitbach, Martin Krause, Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy European Journal of Gastroenterology & Hepatology. ,vol. 14, pp. 1393- 1395 ,(2002) , 10.1097/00042737-200212000-00018
Todd Ellerin, Robert H. Rubin, Michael E. Weinblatt, Infections and anti–tumor necrosis factor α therapy Arthritis & Rheumatism. ,vol. 48, pp. 3013- 3022 ,(2003) , 10.1002/ART.11301
Joseph Morelli, Frederick A Wilson, Does administration of infliximab increase susceptibility to listeriosis The American Journal of Gastroenterology. ,vol. 95, pp. 841- 842 ,(2000) , 10.1016/S0002-9270(99)00931-4
T. T. MACDONALD, P. HUTCHINGS, M.-Y. CHOY, S. MURCH, A. COOKE, Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clinical and Experimental Immunology. ,vol. 81, pp. 301- 305 ,(2008) , 10.1111/J.1365-2249.1990.TB03334.X
A. G. Oehling, C. A. Akdis, A. Schapowal, K. Blaser, M. Schmitz, H.-U. Simon, Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma. Allergy. ,vol. 52, pp. 144- 154 ,(1997) , 10.1111/J.1398-9995.1997.TB00968.X
Alan Shand, Alastair Forbes, Potential therapeutic role for cytokine or adhesion molecule manipulation in Crohn's disease: in the shadow of infliximab? International Journal of Colorectal Disease. ,vol. 18, pp. 1- 11 ,(2003) , 10.1007/S00384-002-0431-6
Joseph Keane, Sharon Gershon, Robert P. Wise, Elizabeth Mirabile-Levens, John Kasznica, William D. Schwieterman, Jeffrey N. Siegel, M. Miles Braun, Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent The New England Journal of Medicine. ,vol. 345, pp. 1098- 1104 ,(2001) , 10.1056/NEJMOA011110